Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishanu Saha

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2017
Genome Editing in Human Pluripotent Stem CellsJared Carlson-Stevermer, Krishanu Saha
Cell Stem Cell|May 6, 2014
Allying with donors to link health and medical information with stem cell lines can advance disease modeling while enhancing data accessKrishanu Saha, Linda F Hogle
Swiss Medical Weekly|February 11, 2011
Disease modeling using pluripotent stem cells: making sense of disease from bench to bedsideKrishanu Saha, J Benjamin Hurlbut
Drug Discovery Today. Technologies|September 13, 2018
Developing precision medicine using scarless genome editing of human pluripotent stem cellsBenjamin Steyer, Evan Cory, Krishanu Saha
Seminars in Immunopathology|August 16, 2024
Advances in manufacturing chimeric antigen receptor immune cell therapiesApoorva Ramamurthy, Anna Tommasi, Krishanu Saha
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 23, 2026
Focused CRISPR screening to design fit-for-purpose CAR T cell therapiesNina La Vonne Denne, Krishanu Saha
Current Opinion in Biomedical Engineering|May 16, 2019
Increasing the precision of gene editing <i>in vitro</i>, <i>ex vivo,</i> and <i>in vivo</i>Katherine Mueller, Jared Carlson-Stevermer, Krishanu Saha
The CRISPR Journal|October 11, 2019
Democratic Governance of Human Germline Genome EditingSheila Jasanoff, J Benjamin Hurlbut, Krishanu Saha
Cell|November 16, 2010
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issuesJacob H Hanna, Krishanu Saha, Rudolf Jaenisch
Trends in Biotechnology|September 19, 2018
Response to BeriainKrishanu Saha, J Benjamin Hurlbut, Sheila Jasanoff
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Methods in Molecular Biology (Clifton, N.J.)|March 30, 2017
Genome Editing in Human Pluripotent Stem CellsJared Carlson-Stevermer, Krishanu Saha
Cell Stem Cell|May 6, 2014
Allying with donors to link health and medical information with stem cell lines can advance disease modeling while enhancing data accessKrishanu Saha, Linda F Hogle
Swiss Medical Weekly|February 11, 2011
Disease modeling using pluripotent stem cells: making sense of disease from bench to bedsideKrishanu Saha, J Benjamin Hurlbut
Drug Discovery Today. Technologies|September 13, 2018
Developing precision medicine using scarless genome editing of human pluripotent stem cellsBenjamin Steyer, Evan Cory, Krishanu Saha
Seminars in Immunopathology|August 16, 2024
Advances in manufacturing chimeric antigen receptor immune cell therapiesApoorva Ramamurthy, Anna Tommasi, Krishanu Saha
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 23, 2026
Focused CRISPR screening to design fit-for-purpose CAR T cell therapiesNina La Vonne Denne, Krishanu Saha
Current Opinion in Biomedical Engineering|May 16, 2019
Increasing the precision of gene editing <i>in vitro</i>, <i>ex vivo,</i> and <i>in vivo</i>Katherine Mueller, Jared Carlson-Stevermer, Krishanu Saha
The CRISPR Journal|October 11, 2019
Democratic Governance of Human Germline Genome EditingSheila Jasanoff, J Benjamin Hurlbut, Krishanu Saha
Cell|November 16, 2010
Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issuesJacob H Hanna, Krishanu Saha, Rudolf Jaenisch
Trends in Biotechnology|September 19, 2018
Response to BeriainKrishanu Saha, J Benjamin Hurlbut, Sheila Jasanoff
Pageof 10